Evidence map›Paper›PMID 34002064›Full record

ArticleNature biomedical engineering2021

Therapeutic implications of transplanted-cell death.

Zachary W Wagoner, Weian Zhao

Abstract read
PubMed Publisher
In one paragraph

Article in Nature biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zachary W WagonerSue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA, USA.ORCID http://orcid.org/0000-0002-0354-5407
Weian ZhaoSue and Bill Gross Stem Cell Research Center, University of California, Irvine, Irvine, CA, USA. weianz@uci.edu.

Funding

Technology Development P2CHD086843 · NICHD · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI AMBROSIO, FABRISIA · 2015 to 2024
$10.5M
Mechano-sensing stem cells to study, detect and treat cancer metastasesDP2CA195763 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI ZHAO, WEIAN · 2014 to 2014
$2.3M
Mechano-Sensing CAR-T Cells for Solid Tumor MetastasesR21CA219225 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI ZHAO, WEIAN · 2017 to 2018
$376k
NCI NIH HHS DP2 CA195763NCI NIH HHS R21 CA219225NICHD NIH HHS P2C HD086843
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCell- and Tissue-Based TherapyClinical Trials as TopicHumansImmunotherapy, AdoptiveMesenchymal Stem Cell TransplantationParacrine CommunicationReceptors, Chimeric AntigenReceptors, Chimeric Antigen

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.